Here are five key notes:
1. Some of the patents relate to current Nextremity implants, including the Nextra Hammertoe Correction System and MSP Metatarsal Shortening System.
2. There are also patents within the recently-issued group relating to products in Nextremity’s product pipeline.
3. The company works closely with foot and ankle surgeon partners to develop and innovate in the market. These patents are a result of that relationship.
“All of our work at Nextremity Solutions has been focused on designing unique products that make complex foot and ankle surgical procedures more consistently successful,” said co-founder Stuart D. Katchis, MD. “The issuance of these patents and success we have seen clinically confirm the value of our products to surgeons and patients alike.”
More articles on orthopedic devices:
Do patients care about spinal implant material? Yes—And here’s what they prefer
ChoiceSpine gets CE mark for VEO lateral spine system
FDA clears Xtant Medical’s cervical plate
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
